• Users Online: 428
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
LETTER TO EDITOR
Year : 2019  |  Volume : 3  |  Issue : 1  |  Page : 106-108

Dramatic response of cutaneous, nail, and joint symptoms of psoriasis to apremilast


Department of Dermatology, Venereology and Leprosy, Yenepoya Medical College, Mangalore, Karnataka, India

Correspondence Address:
Manjunath M Shenoy
Department of Dermatology, Venereology and Leprosy, Yenepoya Medical College, Deralakatte, Mangalore - 575 018, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/CDR.CDR_12_18

Rights and Permissions

Apremilast has been available in India for the past 6 months as a therapy for psoriasis. A 31-year-old male patient with a diagnosis of psoriasis with oligoarthritis who was not tolerating methotrexate was treated with apremilast. We noticed a dramatic response to the cutaneous and joint symptom within a month of initiation of the therapy. We also noticed improvement in the nail changes. He tolerated the drug except for an episode of diarrhea that resolved without any intervention. Apremilast is a useful addition to the therapeutic armamentarium of psoriasis and arthritis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed107    
    Printed4    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal